Dil B. Begum

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.

Journal: Haematologica

Published: August 31, 2018

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Journal: Leukemia

Published: March 01, 2017

Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.

Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.

Journal: Nature communications

Published: August 20, 2015

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 19, 2015

The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma.

The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 28, 2015

The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.

The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.

Journal: Haematologica

Published: December 07, 2014

Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations.

Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations.

Journal: Blood

Published: November 28, 2014

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.

Journal: Nature communications

Published: October 02, 2014

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.

Journal: Genes, chromosomes & cancer

Published: June 17, 2014

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients.

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients.

Journal: Blood cancer journal

Published: January 30, 2014

Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Journal: Blood

Published: January 23, 2014

Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma.

Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma.

Journal: Leukemia

Published: September 10, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026